Implantica submits U.S. FDA Premarket Approval application for RefluxStop®

Implantica Liechtenstein

for further information.

About RefluxStop™
RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It's unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GERD involve encircling the food passageway to support the lower esophageal sphincter's closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.

In contrast, the RefluxStop device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower esophageal sphincter in its original, natural position.

The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.

Newsroom
https://www.implantica.com/media/media-kit

Community
https://ch.linkedin.com/company/implantica
https://www.twitter.com/implantica

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: [phone]
[e-mail] 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-submits-u-s--fda-premarket-approval--pma--application-for-refluxstop---first-module-,c3953137

The following files are available for download:

https://mb.cision.com/Main/19732/3953137/2699138.pdf

Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module)

https://news.cision.com/implantica/i/logo-transparent-1-8,c3283679

logo transparent 1 8

https://news.cision.com/implantica/i/reluxstop-product,c3283680

ReluxStop Product

 

View original content:https://www.prnewswire.co.uk/news-releases/implantica-submits-us-fda-premarket-approval-pma-application-for-refluxstop-first-module-302100737.html

@ prnewswire.co.uk